This topic contains a solution. Click here to go to the answer

Author Question: In the above figure, what could cause the shift of aggregate demand fromAD1 to AD2? A) depletion ... (Read 39 times)

vicotolentino

  • Hero Member
  • *****
  • Posts: 552
In the above figure, what could cause the shift of aggregate demand fromAD1 to AD2?
 
  A) depletion of raw materials B) an increase in international trade barriers
  C) a decrease in consumer confidence D) an increase in input prices

Question 2

Final goods and services are those that are
 
  A) sold to ultimate or final purchasers.
  B) produced outside the United States.
  C) double counted in the calculation of GDP.
  D) used in the production of other goods and services.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

jamesnevil303

  • Sr. Member
  • ****
  • Posts: 337
Answer to Question 1

C

Answer to Question 2

A





 

Did you know?

The senior population grows every year. Seniors older than 65 years of age now comprise more than 13% of the total population. However, women outlive men. In the 85-and-over age group, there are only 45 men to every 100 women.

Did you know?

Your heart beats over 36 million times a year.

Did you know?

The cure for trichomoniasis is easy as long as the patient does not drink alcoholic beverages for 24 hours. Just a single dose of medication is needed to rid the body of the disease. However, without proper precautions, an individual may contract the disease repeatedly. In fact, most people develop trichomoniasis again within three months of their last treatment.

Did you know?

Amoebae are the simplest type of protozoans, and are characterized by a feeding and dividing trophozoite stage that moves by temporary extensions called pseudopodia or false feet.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library